Publication | Closed Access

Nicotinamide mononucleotide (NMN) treatment attenuates oxidative stress and rescues angiogenic capacity in aged cerebromicrovascular endothelial cells: a potential mechanism for the prevention of vascular cognitive impairment

Nicotinamide MononucleotideMedicineEndothelial DysfunctionVascular Cognitive ImpairmentVascular BiologyNeuroprotectionNeurologyNeuroscienceCerebral Blood FlowCerebral Vascular RegulationPharmacologyAtherosclerosisOxidative StressVascular Aging